Insights

Industry Trends & Updates

Core Issues That Terminate the MDR Conformity Assessment

Jul 7, 2025

Non-cormity of MDR conformity assessment stems from inadequate technical documentation, insufficient clinical evidence, and deficient QMS and risk management.

Empowering Innovation within EIC Partnership Ecosystem

Apr 7, 2025

After the EIC Summit 2025 and EIC Partners Day, it is a good time to reflect on the past year of ecosystem partnership with the European Innovation Council (EIC) for internationalisation. Looking back to 2023, when EIC decided to expand their EIC service catalogue...

Financial Modeling for EIC Awardees and Seal of Excellence Holders

Jan 21, 2025

inXso is dedicated to supporting EIC Awardees and Seal of Excellence Holders in their venture building in the healthcare sector.

inXso Joins SHIFT-HUB as an Official Partnership Organisation

Aug 15, 2024

inXso is delighted to announce our joining of an official partnership organisation with SHIFT-HUB, a pan-European Smart Health Innovation Hub.

Catalysing Breakthroughs in Deep Tech

May 6, 2024

The EIC Fund is uniquely positioned to finance innovations based on scientific discoveries or emerging technologies, catalysing breakthroughs in Deep Tech.

Beyond the Brain: The Role of Gut Health in Autism Spectrum Disorder

Apr 2, 2024

Autism Spectrum Disorder (ASD) is a complex neurodevelopmental condition characterised by challenges in social interaction, communication, and repetitive behaviours.

International Reimbursement Strategy for Orthopaedic Therapy Device

Mar 4, 2024

Leverage inXso’s expertise to create a successful reimbursement strategy and identify optimal countries regarding market introduction and revenue realisation.

Clinical Evaluation & Investigation of Active Therapeutic Device

Feb 12, 2024

Case study to transit an active therapeutic device from the preclinical to the clinical phase using clinical design, development and regulatory considerations.

Conquering Cancer: Insights and Innovations from World Cancer Day 2024

Feb 2, 2024

Despite the surge of scientific and technological advancements in cancer prevention, diagnosis and treatment, cancer is the leading cause of death worldwide.

« Older Entries

WHO DO WE WORK WITH

[wdcl_logo_carousel nav_pagi="none" is_auto_height="on" slide_count_tablet="2" slide_count_phone="1" slide_count_last_edited="on|phone" _builder_version="4.24.3" _module_preset="default" global_colors_info="{}"][wdcl_logo_carousel_child admin_title="EICpartners" logo="https://inxso.pro/wp-content/uploads/2024/04/EIC-partner.png" _builder_version="4.24.3" _module_preset="default" global_colors_info="{}"][/wdcl_logo_carousel_child][wdcl_logo_carousel_child admin_title="RedWheel" logo="https://inxso.pro/wp-content/uploads/2024/04/RedWheel.png" _builder_version="4.24.3" _module_preset="default" global_colors_info="{}"][/wdcl_logo_carousel_child][wdcl_logo_carousel_child admin_title="FBC" logo="https://inxso.pro/wp-content/uploads/2022/08/FBC.png" _builder_version="4.18.0" _module_preset="default" background_enable_image="off" global_colors_info="{}"][/wdcl_logo_carousel_child][wdcl_logo_carousel_child admin_title="DBusiness International" logo="https://inxso.pro/wp-content/uploads/2022/08/DBusiness-International-1.png" _builder_version="4.18.0" _module_preset="default" background_enable_image="off" global_colors_info="{}"][/wdcl_logo_carousel_child][wdcl_logo_carousel_child admin_title="ProActive" logo="https://inxso.pro/wp-content/uploads/2022/08/ProActive.png" _builder_version="4.18.0" _module_preset="default" background_enable_image="off" global_colors_info="{}"][/wdcl_logo_carousel_child][wdcl_logo_carousel_child admin_title="BSC" logo="https://inxso.pro/wp-content/uploads/2022/08/BSC.png" _builder_version="4.18.0" _module_preset="default" global_colors_info="{}"][/wdcl_logo_carousel_child][wdcl_logo_carousel_child admin_title="SlushChina" logo="https://inxso.pro/wp-content/uploads/2022/08/SlushChina.png" _builder_version="4.18.0" _module_preset="default" global_colors_info="{}"][/wdcl_logo_carousel_child][wdcl_logo_carousel_child admin_title="Seqvera" logo="https://inxso.pro/wp-content/uploads/2022/08/Seqvera.png" _builder_version="4.18.0" _module_preset="default" global_colors_info="{}"][/wdcl_logo_carousel_child][wdcl_logo_carousel_child admin_title="KasvuOpen sparraaja" logo="https://inxso.pro/wp-content/uploads/2022/09/KO-sparraajalogo_2022.png" _builder_version="4.18.0" _module_preset="default" global_colors_info="{}"][/wdcl_logo_carousel_child][wdcl_logo_carousel_child admin_title="DBusiness" logo="https://inxso.pro/wp-content/uploads/2022/08/DBusiness.png" _builder_version="4.18.0" _module_preset="default" global_colors_info="{}"][/wdcl_logo_carousel_child][wdcl_logo_carousel_child admin_title="Tre HealthHub" logo="https://inxso.pro/wp-content/uploads/2022/09/Tre-HealthHUB.png" _builder_version="4.24.0" _module_preset="default" global_colors_info="{}"][/wdcl_logo_carousel_child][wdcl_logo_carousel_child admin_title="Propellerhat funding" logo="https://inxso.pro/wp-content/uploads/2024/04/Propellerhat-funding.png" _builder_version="4.24.3" _module_preset="default" global_colors_info="{}"][/wdcl_logo_carousel_child][/wdcl_logo_carousel]



Office

Biokatu 12, FinnMedi 5

33520 Tampere

Finland